Page last updated: 2024-08-16

propranolol and bisoprolol

propranolol has been researched along with bisoprolol in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	16 (23.88)	18.7374
1990's	10 (14.93)	18.2507
2000's	16 (23.88)	29.6817
2010's	21 (31.34)	24.3611
2020's	4 (5.97)	2.80

Authors

Authors	Studies
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H	1
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Baker, JG	1
Abraham, MH; Acree, WE; Ibrahim, A	1
Carrupt, PA; Guillarme, D; Henchoz, Y; Rudaz, S; Veuthey, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Bard, B; Carrupt, PA; Martel, S	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Charlton, SJ; Dickson, CJ; Duca, JS; Fairhurst, RA; Hornak, V; McKay, DJ; Pearlstein, RA; Reilly, J; Sandham, DA; Shaw, D; Sykes, DA; Velez-Vega, C	1
Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J	1
Abella, ML; Dubreuil, C; Fleury, B; Provendier, O; Pujet, JC	1
d'Hollander, A; Goldstein, M; Kahn, RJ; Le Clerc, JL; Melot, C; Vincent, JL	1
Mauz, AB; Pelzer, H	1
Cheymol, G	1
Brodde, OE	1
Belz, GG; Palm, D; Wellstein, A	2
Belz, GG; Bühring, KU; Leopold, G; Pabst, J; Palm, D; Wellstein, A	1
Hieda, N; Ito, T; Ogawa, T; Ozawa, T; Satake, T; Sugiyama, S	1
Kaumann, AJ; Lemoine, H	1
Bühring, KU; Leopold, G; Pabst, J; Simane, Z; Ungethüm, W; Wiemann, H	1
Bühring, KU; Garbe, A	1
Beckeringh, JJ; Brodde, OE; Ikezono, K; Michel, MC; Zerkowski, HR	1
Duncker, DJ; Saxena, PR; Verdouw, PD	1
Belz, GG; Butzer, R; Palm, D; Pett, B; Polsak, R; Wellstein, A	1
Bailliart, O; Bonnin, P; Kedra, AW; Martineaud, JP; Savin, E	1
Joubert, PH; Venter, CP; Wellstein, A	1
Haeusler, G; Harting, J; Schliep, HJ; Schulze, E	1
Bacon, RJ; Cragg, DJ; Tattersfield, AE	1
Brodde, OE; Daul, A; Hermes, U; Schäfers, RF; von Birgelen, C; Wenzel, R	1
Böhm, M; Emslander, HP; Hauck, RW; Schulz, C	1
Boomsma, F; Brodde, OE; Daul, A; Elter-Schulz, M; Jockenhövel, F; Man in't Veld, AJ; Poller, U; Pönicke, K; Schäfes, RF	1
Carrupt, PA; Cheymol, G; Levron, JC; Poirier, JM; Snoeck, E; Testa, B; Weissenburger, J	1
Corradi, L; Fogari, R; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A	1
Carson, PE	1
Bertsch, D; Brehm, BR; Klaussner, M; Schüler, S; Schulze-Osthoff, K; Wesselborg, S; Wolf, SC	1
Kahonen, M; Koobi, T; Turjanmaa, V; Ylitalo, P; Ylitalo, R	1
Cruickshank, JM	1
Abou-Sekkina, MM; El-Ries, MA; Hassan, SS; Wassel, A	1
Auge, D; Bachmakov, I; Endress, B; Fromm, MF; Werner, U	1
Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C	1
Sal'nikov, EV	1
Bachmakov, I; Endress, B; Fromm, MF; Glaeser, H; König, J; Mörl, F	1
Brett, SE; Chowienczyk, PJ; Cockburn, JA; Ferro, A; Guilcher, A; Ritter, JM	1
Cai, H; Chen, WQ; Ji, XP; Zhang, C; Zhang, Y	1
Ma, M; Ouyang, L; Su, X; Xie, Q; Yao, S; Zhang, C; Zhang, L	1
Lopes, CM; O-Uchi, J	1
Abdelkrim, MA; Chatagnon, G; Desfontis, JC; Gogny, M; Mallem, MY; Noireaud, J	1
Onay-Besikci, A; Ozcelikay, AT; Suzmecelik, E	1
Briese, V; Richter, C; Richter, DU; Szewczyk, M	1
Cvan Trobec, K; Kerec Kos, M; Lainscak, M; Springer, J; Trontelj, J	1
Giebułtowicz, J; Nałęcz-Jawecki, G; Sikorska, K; Stankiewicz, A; Stefański, M; Wroczyński, P	1
Jensen, SM; Kesek, M; Rydberg, A	1
Collins, C; Kerbusch, V; Korstanje, C; Meijer, J; Stölzel, M; van Gelderen, M	1
Byun, JI; Chu, K; Jun, JS; Jung, KH; Jung, KY; Kim, DY; Kim, M; Kim, TJ; Lee, HS; Lee, SK; Lee, ST; Lee, WJ; Lim, JA; Moon, J; Park, B; Park, KI; Sunwoo, JS	1
Addison, D; Alam, M; Jneid, H; Kayani, W; Lakkis, N; Misra, A; Pham, D; Resar, J	1
Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B	1
Ashidate, K; Fujita, Y; Ito, T; Kikuchi, K; Kikuchi, T; Kikuchi, Y; Komano, H; Liu, J; Maeda, T; Niibori, S; Nishikata, D; Shen, X; Terakawa, T; Zou, K	1
Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H	1
Chen, YW; Hsu, CW; Huang, KY; Lin, CH; Lin, PY; Matsuoka, YJ; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wu, YC	1

Reviews

6 review(s) available for propranolol and bisoprolol

Article	Year
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists. Journal of medicinal chemistry, 1988, Volume: 31, Issue:11 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship	1988
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Beta-blocker therapy in heart failure: pathophysiology and clinical results. Current problems in cardiology, 1999, Volume: 24, Issue:7 Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol	1999
Beta-blockers and diabetes: the bad guys come good. Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:5 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bisoprolol; Coronary Disease; Diabetes Mellitus, Type 2; Humans; Hypertension; Metoprolol; Myocardial Infarction; Prognosis; Propranolol	2002
Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis. Emergency medicine journal : EMJ, 2018, Volume: 35, Issue:9 Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carvedilol; Cocaine; Humans; Metoprolol; Propanolamines; Propranolol	2018
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials. Scientific reports, 2021, 01-11, Volume: 11, Issue:1 Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Cardiovascular Diseases; Celiprolol; Disease Progression; Female; Humans; Incidence; Infusions, Intravenous; Male; Practolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Sotalol; Status Asthmaticus; Timolol	2021

Trials

13 trial(s) available for propranolol and bisoprolol

Article	Year
Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients. The European respiratory journal, 1992, Volume: 5, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Asthma; Bisoprolol; Bronchoconstriction; Celiprolol; Double-Blind Method; Female; Forced Expiratory Volume; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Propranolol; Vital Capacity	1992
Hemodynamic evaluation of bisoprolol after coronary artery surgery in patients with altered left ventricular function. Cardiovascular drugs and therapy, 1991, Volume: 5, Issue:3 Topics: Adrenergic beta-Antagonists; Bisoprolol; Coronary Artery Bypass; Hemodynamics; Humans; Propanolamines; Propranolol; Ventricular Function, Left	1991
Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist. British journal of clinical pharmacology, 1986, Volume: 22, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Dose-Response Relationship, Drug; Heart Rate; Humans; Male; Metoprolol; Physical Exertion; Propanolamines; Propranolol; Time Factors	1986
Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy. European heart journal, 1987, Volume: 8 Suppl M Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Double-Blind Method; Exercise Test; Heart Rate; Humans; Male; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tachycardia	1987
Effects of bisoprolol on local vascular resistance. European heart journal, 1987, Volume: 8 Suppl M Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Blood Pressure; Brachial Artery; Double-Blind Method; Female; Femoral Artery; Heart Rate; Humans; Male; Propanolamines; Propranolol; Random Allocation; Regional Blood Flow; Vascular Resistance	1987
Ethnic differences in response to beta-blockade: fact or artefact? A study with bisoprolol and propranolol. European journal of clinical pharmacology, 1988, Volume: 34, Issue:4 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Bisoprolol; Black People; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Humans; Male; Physical Exertion; Propanolamines; Propranolol; United States; White People	1988
Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man. British journal of clinical pharmacology, 1984, Volume: 18, Issue:3 Topics: Adrenergic beta-Antagonists; Bisoprolol; Bronchi; Dose-Response Relationship, Drug; Heart Rate; Humans; Metoprolol; Physical Exertion; Propanolamines; Propranolol; Receptors, Adrenergic, beta	1984
Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers. British journal of clinical pharmacology, 1997, Volume: 43, Issue:6 Topics: Adipose Tissue; Adrenergic beta-Antagonists; Adult; Area Under Curve; Benzopyrans; Binding Sites; Bisoprolol; Blood Chemical Analysis; Blood Pressure; Cardiac Output; Chromatography, High Pressure Liquid; Ethanolamines; Female; Heart Rate; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Labetalol; Male; Nebivolol; Obesity; Propranolol; Regression Analysis; Sotalol; Stereoisomerism; Tissue Distribution	1997
Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia. Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:4 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Bisoprolol; Celiprolol; Double-Blind Method; Humans; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Propranolol	1999
Influences of nonselective, beta(1)-selective and vasodilatory beta(1)-selective beta-blockers on arterial pulse wave velocity in normotensive subjects. General pharmacology, 2000, Volume: 35, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Blood Pressure; Celiprolol; Double-Blind Method; Female; Humans; Male; Propranolol; Pulse; Receptors, Adrenergic, beta-1; Vasodilator Agents	2000
Differential effects of beta-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise. British journal of clinical pharmacology, 2010, Volume: 69, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Bisoprolol; Blood Pressure; Brachial Artery; Cross-Over Studies; Diastole; Double-Blind Method; Exercise; Female; Heart Rate; Humans; Male; Middle Aged; Propranolol; Systole; Vascular Resistance; Young Adult	2010
An Exploratory Study in Healthy Male Subjects of the Mechanism of Mirabegron-Induced Cardiovascular Effects. Journal of clinical pharmacology, 2017, Volume: 57, Issue:12 Topics: Acetanilides; Adolescent; Adrenergic beta-3 Receptor Agonists; Adult; Area Under Curve; Bisoprolol; Cardiac Output; Cross-Over Studies; Humans; Male; Propranolol; Renin; Stroke Volume; Thiazoles; Young Adult	2017
Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2018, Volume: 15, Issue:3 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Bisoprolol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Postural Orthostatic Tachycardia Syndrome; Propranolol; Pyridostigmine Bromide; Retrospective Studies; Severity of Illness Index; Time Factors; Young Adult	2018

Other Studies

48 other study(ies) available for propranolol and bisoprolol

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. British journal of pharmacology, 2005, Volume: 144, Issue:3 Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3	2005
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs. European journal of medicinal chemistry, 2008, Volume: 43, Issue:3 Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization	2008
High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists. Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3 Topics: Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, Liquid; Mathematics; Pharmaceutical Preparations; Software	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography. Journal of medicinal chemistry, 2009, May-28, Volume: 52, Issue:10 Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding. Journal of medicinal chemistry, 2016, 06-23, Volume: 59, Issue:12 Topics: Binding Sites; Cell Membrane; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, Adrenergic, beta-2; Structure-Activity Relationship	2016
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents. Bioorganic & medicinal chemistry, 2020, 05-01, Volume: 28, Issue:9 Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured	2020
Beta-adrenoceptor-binding studies of the cardioselective beta blockers bisoprolol, H-I 42 BS, and HX-CH 44 BS to heart membranes and intact ventricular myocytes of adult rats: two beta 1-binding sites for bisoprolol. Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:3 Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Cell Membrane; In Vitro Techniques; Isoquinolines; Male; Myocardium; Propanolamines; Propranolol; Quinazolinones; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta	1990
[Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects]. Bulletin de l'Academie nationale de medecine, 1990, Volume: 174, Issue:7 Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Female; Humans; Male; Obesity; Propanolamines; Propranolol; Sotalol	1990
Bisoprolol (EMD 33512), a highly selective beta 1-adrenoceptor antagonist: in vitro and in vivo studies. Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 11 Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Isoproterenol; Lung; Lymphocytes; Membranes; Pindolol; Propanolamines; Propranolol; Rabbits; Receptors, Adrenergic, beta; Renin; Sympathomimetics	1986
Affinity and selectivity of beta-adrenoceptor antagonists in vitro. Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 11 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Binding, Competitive; Bisoprolol; Propanolamines; Propranolol; Rats; Salivary Glands; Tritium	1986
Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay. Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 11 Topics: Adrenergic beta-Antagonists; Adult; Animals; Atenolol; Bisoprolol; Chemistry, Physical; Humans; Kinetics; Male; Osmolar Concentration; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta	1986
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia. Heart and vessels, 1989, Volume: 5, Issue:1 Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coronary Circulation; Coronary Disease; Dogs; Female; Glucuronidase; Heart Failure; Heart Rate; Lysosomes; Male; Mitochondria, Heart; Myocardial Contraction; Myocardial Infarction; Propanolamines; Propranolol; Ventricular Fibrillation	1989
Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 246, Issue:1 Topics: Adult; Algorithms; Bisoprolol; Blood Pressure; Dose-Response Relationship, Drug; Humans; Isoproterenol; Male; Propanolamines; Propranolol; Receptors, Adrenergic, beta	1988
Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency. Naunyn-Schmiedeberg's archives of pharmacology, 1985, Volume: 331, Issue:1 Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Bisoprolol; Catecholamines; Cats; Epinephrine; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Male; Membranes; Myocardial Contraction; Myocardium; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Sinoatrial Node; Stereoisomerism	1985
Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography. Journal of chromatography, 1986, Oct-31, Volume: 382 Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Kinetics; Metoprolol; Propanolamines; Propranolol	1986
The role of cyclic AMP in the positive inotropic effect mediated by beta 1- and beta 2-adrenoceptors in isolated human right atrium. Naunyn-Schmiedeberg's archives of pharmacology, 1987, Volume: 335, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cyclic AMP; Electric Stimulation; Female; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Myocardium; Papaverine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stimulation, Chemical	1987
Systemic haemodynamic and beta-adrenoceptor antagonistic effects of bisoprolol in conscious pigs: a comparison with propranolol. Archives internationales de pharmacodynamie et de therapie, 1987, Volume: 290, Issue:1 Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Dose-Response Relationship, Drug; Heart; Hemodynamics; Isoproterenol; Propanolamines; Propranolol; Swine	1987
Antagonistic effects of bisoprolol on several beta-adrenoceptor-mediated actions in anaesthetized cats. European journal of pharmacology, 1986, Apr-16, Volume: 123, Issue:2 Topics: Anesthesia; Animals; Atenolol; Bisoprolol; Blood Pressure; Bronchi; Cardiovascular Physiological Phenomena; Cardiovascular System; Cats; Female; Heart Rate; Isoproterenol; Male; Muscle Contraction; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Respiration	1986
The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers. International journal of clinical pharmacology and therapeutics, 1995, Volume: 33, Issue:3 Topics: Adult; Bisoprolol; Blood Pressure; Dobutamine; Dose-Response Relationship, Drug; Epinephrine; Heart Rate; Humans; Infusions, Intravenous; Male; Propranolol; Receptors, Adrenergic, beta; Tachycardia	1995
Pharmacological actions of the selective and non-selective beta-adrenoceptor antagonists celiprolol, bisoprolol and propranolol on human bronchi. British journal of pharmacology, 1994, Volume: 113, Issue:3 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Bronchi; Celiprolol; Dose-Response Relationship, Drug; Female; Guanylyl Imidodiphosphate; Heart; Humans; Male; Middle Aged; Pindolol; Propranolol	1994
Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers. Naunyn-Schmiedeberg's archives of pharmacology, 1995, Volume: 352, Issue:4 Topics: Adult; Bisoprolol; Blood Pressure; Deoxyepinephrine; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Heart Rate; Humans; Male; Norepinephrine; Prolactin; Propranolol; Receptors, Adrenergic; Receptors, Dopamine; Sympathomimetics	1995
Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells. Cardiovascular research, 2001, Feb-01, Volume: 49, Issue:2 Topics: Adrenergic beta-Antagonists; Apoptosis; Becaplermin; Benzopyrans; Bisoprolol; Cell Culture Techniques; Cell Division; Cells, Cultured; Depression, Chemical; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Endothelium, Vascular; Ethanolamines; Gene Expression; Humans; In Situ Hybridization; Male; Metoprolol; Muscle, Smooth, Vascular; Nebivolol; Nitric Oxide; Platelet-Derived Growth Factor; Propranolol; Protein Precursors; Proto-Oncogene Proteins c-sis; RNA, Messenger; Transforming Growth Factor beta	2001
Polymeric matrix membrane sensors for sensitive potentiometric determination of some beta-blockers in pharmaceutical preparations. Journal of pharmaceutical and biomedical analysis, 2003, Apr-24, Volume: 32, Issue:1 Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Indicators and Reagents; Ions; Metoprolol; Phosphates; Polyvinyl Chloride; Potentiometry; Propranolol; Sensitivity and Specificity; Timolol; Tungsten Compounds	2003
Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein. Fundamental & clinical pharmacology, 2006, Volume: 20, Issue:3 Topics: Adrenergic beta-Antagonists; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bisoprolol; Caco-2 Cells; Carbazoles; Carvedilol; Cyclosporins; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Humans; Propanolamines; Propranolol; Time Factors	2006
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Mar-01, Volume: 847, Issue:2 Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil	2007
Heart rate variability in rats with experimental chronic heart failure and long-term exposure to beta-adrenoblockers. Bulletin of experimental biology and medicine, 2009, Volume: 147, Issue:2 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzopyrans; Bisoprolol; Ethanolamines; Heart Failure; Heart Rate; Male; Metoprolol; Nebivolol; Pindolol; Propranolol; Rats	2009
Interaction of beta-blockers with the renal uptake transporter OCT2. Diabetes, obesity & metabolism, 2009, Volume: 11, Issue:11 Topics: Adrenergic beta-Antagonists; Biological Transport; Bisoprolol; Carbazoles; Carvedilol; Cell Line; Humans; Kidney; Metformin; Metoprolol; Organic Cation Transport Proteins; Organic Cation Transporter 2; Propanolamines; Propranolol	2009
Is overall blockade superior to selective blockade of adrenergic receptor subtypes in suppressing left ventricular remodeling in spontaneously hypertensive rats? Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:10 Topics: Adrenergic Antagonists; Animals; Apoptosis; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Disease Models, Animal; Heart Rate; Humans; Hypertension; Myocytes, Cardiac; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Ventricular Remodeling	2010
Extraction and preconcentration of beta-blockers in human urine for analysis with high performance liquid chromatography by means of carrier-mediated liquid phase microextraction. Talanta, 2010, Aug-15, Volume: 82, Issue:3 Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Carteolol; Chromatography, High Pressure Liquid; Humans; Limit of Detection; Propranolol; Reproducibility of Results; Sotalol	2010
Combined blockade of β- and α₁-adrenoceptors in left ventricular remodeling induced by hypertension: beneficial or not? Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:10 Topics: Adrenergic Antagonists; Animals; Bisoprolol; Carbazoles; Carvedilol; Disease Models, Animal; Humans; Hypertension; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Ventricular Remodeling	2010
Autoantibodies against cardiac β(1)-adrenoceptor do not affect the low-affinity state β(1)-adrenoceptor-mediated inotropy in rat cardiomyocytes. Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:4 Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Autoantibodies; Bisoprolol; Isoproterenol; Male; Myocardial Contraction; Myocytes, Cardiac; Phosphodiesterase Inhibitors; Pindolol; Propanolamines; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1	2012
Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells. Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Bisoprolol; Carbazoles; Carvedilol; Cell Line; Epinephrine; Fatty Acids; Glycolysis; Mice; Oxidation-Reduction; Palmitic Acid; Prazosin; Propanolamines; Propranolol; Sympathomimetics	2012
A retrospective in vitro study of the impact of anti-diabetics and cardioselective pharmaceuticals on breast cancer. Anticancer research, 2012, Volume: 32, Issue:5 Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Blood Glucose; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hypertension; Hypoglycemic Agents; Metformin; Oxidative Stress; Propranolol; Retrospective Studies; Thiazolidinediones	2012
Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of bisoprolol, ramiprilat, propranolol and midazolam in rat dried blood spots. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2014, May-01, Volume: 958 Topics: Animals; Antihypertensive Agents; Bisoprolol; Chromatography, Liquid; Dried Blood Spot Testing; Hypnotics and Sedatives; Limit of Detection; Male; Midazolam; Propranolol; Ramipril; Rats; Rats, Wistar; Tandem Mass Spectrometry	2014
The development of the LC-MS/MS method based on S-9 biotransformation for detection of metabolites of selected β-adrenolytics in surface water. Environmental toxicology and pharmacology, 2015, Volume: 39, Issue:2 Topics: Adrenergic beta-Antagonists; Animals; Biotransformation; Bisoprolol; Chromatography, Liquid; Liver; Male; Metoprolol; Poland; Propranolol; Rats, Sprague-Dawley; Rivers; Tandem Mass Spectrometry; Waste Disposal, Fluid; Water Pollutants, Chemical	2015
Two Cases of LQT Syndrome with Malignant Syncope after Switch from Propranolol to Bisoprolol. Pacing and clinical electrophysiology : PACE, 2016, Volume: 39, Issue:3 Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Bisoprolol; Drug Administration Schedule; Humans; Long QT Syndrome; Male; Propranolol; Syncope; Treatment Outcome; Young Adult	2016
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019, Oct-15, Volume: 1129 Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil	2019
Interaction between Angiotensin Receptor and β-Adrenergic Receptor Regulates the Production of Amyloid β-Protein. Biological & pharmaceutical bulletin, 2020, Volume: 43, Issue:4 Topics: Adrenergic beta-Antagonists; Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Bisoprolol; Cells, Cultured; Mice, Inbred C57BL; Propanolamines; Propranolol; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, beta-2; Telmisartan	2020
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021, Volume: 77, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors	2021